June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
Rapid high-yield production of rhodopsin knockout Xenopus laevis using CRISPR/Cas9
Author Affiliations & Notes
  • Joanna M Feehan
    Ophthalmology & Visual Sciences, University of British Columbia, Vancouver, BC, Canada
  • Beatrice M Tam
    Ophthalmology & Visual Sciences, University of British Columbia, Vancouver, BC, Canada
  • Orson L Moritz
    Ophthalmology & Visual Sciences, University of British Columbia, Vancouver, BC, Canada
  • Footnotes
    Commercial Relationships Joanna Feehan, None; Beatrice Tam, None; Orson Moritz, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 3590. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Joanna M Feehan, Beatrice M Tam, Orson L Moritz; Rapid high-yield production of rhodopsin knockout Xenopus laevis using CRISPR/Cas9. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):3590.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Xenopus laevis is a widely used animal model in vision research, and, although transgenic X. laevis are generated relatively easily; researchers have previously been unable to engineer knockouts (KO) or knockdowns in X. laevis. New techniques for genome editing using CRISPR/Cas9 have been applied to related organisms, including Xenopus tropicalis. Our goal is to develop a CRISPR/Cas9-based technique for genome editing in X. laevis, using the Rhodopsin (RHO) gene as an initial target. RHO KO X. laevis may be useful for investigating trafficking properties of rhodopsin mutants in the absence of wild-type endogenous rhodopsin. Rhodopsin KO animals are anticipated to have a phenotype that is easily detected by histology (no rod outer segments in complete KO), immunoassay (reduced rhodopsin) and physiology (reduced or no rod electroretinogram (ERG)).

Methods: We designed sequence-specific single-guide RNAs (sgRNAs) to target the X. laevis RHO gene, and injected them into fertilized X. laevis eggs in combination with mRNA encoding Cas9. At 14 days post-fertilization, rhodopsin levels in the eyes of the resulting animals were determined by immunoassay and compared to rhodopsin levels from uninjected animals and animals injected with null sgRNA. We optimized the procedure by varying the temperature, sgRNA target-site specificity, sgRNA concentration, and use of recombinant Cas9.

Results: Our current procedure results in approximately 50% reduction in the average rhodopsin protein levels in injected embryos, indicating that the majority of animals have at least a partial KO phenotype. The retinal phenotype of these mutants included missing or shortened rod outer segments relative to wild-type embryos. The results suggest chimeric KO in the majority of animals.

Conclusions: CRISPR/Cas9-based techniques can result in very high KO rates in X. laevis. The efficiency is sufficiently high that phenotypes can be successfully examined in primary KO animals.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×